Crossmark

Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux

Crossref DOI link: https://doi.org/10.1007/s00405-018-5079-0

Published Online: 2018-07-30

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wilkie, Mark D.

Fraser, Helen M.

Raja, Hemal
License Information

Text and Data Mining valid from 2018-07-30
More Information

Article History

Received: 30 March 2018

Accepted: 26 July 2018

First Online: 30 July 2018

Compliance with ethical standards

:

: The author(s) declare that they have no conflict of interest.